Understanding Kidney Cancer Growth Driven by L-2HG
Interaction between the Epitranscriptome and Metabolism in L-2HG Driven Kidney Cancer
This work explores how a molecule called L-2HG helps kidney cancer grow, aiming to find new ways to help patients with advanced disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11141123 on NIH RePORTER |
What this research studies
We know that kidney cancer can be very challenging for patients with advanced disease, and new treatments are urgently needed. Our team has found that a specific molecule, L-2HG, is often elevated in kidney cancer cells and seems to drive their growth. This project looks closely at how L-2HG changes the genetic instructions within cancer cells and how it affects their metabolism, which is how cells get energy. By understanding these detailed processes, we hope to uncover new targets for future therapies.
Who could benefit from this research
Good fit: This foundational work is not directly recruiting patients but focuses on understanding the biology of kidney cancer, particularly those with L-2HG elevations.
Not a fit: Patients whose kidney cancer does not involve elevated L-2HG or those seeking immediate treatment options may not directly benefit from this basic science research.
Why it matters
Potential benefit: If successful, this work could lead to the development of new and more effective treatments for patients with advanced kidney cancer.
How similar studies have performed: This project explores novel connections between L-2HG, RNA modifications, and metabolism in kidney cancer, building on preliminary findings that suggest these are intricately linked.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Sudarshan, Sunil — University of Alabama at Birmingham
- Study coordinator: Sudarshan, Sunil
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.